These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9210689)

  • 1. Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia.
    Drehobl M; Bianchi P; Keyserling CH; Tack KJ; Griffin TJ
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1579-83. PubMed ID: 9210689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study on cefdinir and cefaclor in the treatment of patients with mild to moderate bacterial community acquired pneumonia].
    Jiang XT; Du YP; Deng LP
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1876-8. PubMed ID: 15631797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection.
    Leigh AP; Nemeth MA; Keyserling CH; Hotary LH; Tack KJ
    Clin Ther; 2000 Jul; 22(7):818-25. PubMed ID: 10945508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized, double-masked, comparative, multicenter study.
    Donowitz GR; Brandon ML; Salisbury JP; Harman CP; Tipping DM; Urick AE; Talbot GH
    Clin Ther; 1997; 19(5):936-53. PubMed ID: 9385482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis.
    Paster RZ; McAdoo MA; Keyserling CH; Nemeth MA; Tack KJ; Griffin TJ
    Int J Clin Pract; 2000 Jun; 54(5):293-9. PubMed ID: 10954955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study Group.
    Gwaltney JM; Savolainen S; Rivas P; Schenk P; Scheld WM; Sydnor A; Keyserling C; Leigh A; Tack KJ
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1517-20. PubMed ID: 9210677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis.
    Fogarty CM; Bettis RB; Griffin TJ; Keyserling CH; Nemeth MA; Tack KJ
    J Antimicrob Chemother; 2000 Jun; 45(6):851-8. PubMed ID: 10837440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM; Scott LJ
    Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.
    File TM; Segreti J; Dunbar L; Player R; Kohler R; Williams RR; Kojak C; Rubin A
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1965-72. PubMed ID: 9303395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.
    Higuera F; Hidalgo H; Feris J; Giguere G; Collins JJ
    J Antimicrob Chemother; 1996 Mar; 37(3):555-64. PubMed ID: 9182112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
    McCarty J; Ruoff GE; Jacobson KD
    Am J Med; 1992 Jun; 92(6A):80S-85S. PubMed ID: 1621751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefdinir versus cephalexin for the treatment of skin and skin-structure infections. The Cefdinir Adult Skin Infection Study Group.
    Tack KJ; Littlejohn TW; Mailloux G; Wolf MM; Keyserling CH
    Clin Ther; 1998; 20(2):244-56. PubMed ID: 9589816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefditoren pivoxil versus cefpodoxime proxetil for community-acquired pneumonia: results of a multicenter, prospective, randomized, double-blind study.
    van Zyl L; le Roux JG; LaFata JA; Volk RS; Palo WA; Flamm R; Hom RC
    Clin Ther; 2002 Nov; 24(11):1840-53. PubMed ID: 12501878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefdinir: an advanced-generation, broad-spectrum oral cephalosporin.
    Guay DR
    Clin Ther; 2002 Apr; 24(4):473-89. PubMed ID: 12017394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation.
    Nicholson SC; Welte T; File TM; Strauss RS; Michiels B; Kaul P; Balis D; Arbit D; Amsler K; Noel GJ
    Int J Antimicrob Agents; 2012 Mar; 39(3):240-6. PubMed ID: 22230331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
    Dere WH; Farlow D; Therasse DG; Ruoff GE
    Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefaclor advanced formulation versus cefaclor in the treatment of pneumonia.
    Casali L; Voi M; Janssen CJ; Olovich KG; Dere WH
    Clin Ther; 1992; 14(4):570-7. PubMed ID: 1525791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter comparative study of cefepime versus broad-spectrum antibacterial therapy in moderate and severe bacterial infections.
    Badaró R; Molinar F; Seas C; Stamboulian D; Mendonça J; Massud J; Nascimento LO;
    Braz J Infect Dis; 2002 Oct; 6(5):206-18. PubMed ID: 12495602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
    Giordano PA; Elston D; Akinlade BK; Weber K; Notario GF; Busman TA; Cifaldi M; Nilius AM
    Curr Med Res Opin; 2006 Dec; 22(12):2419-28. PubMed ID: 17257456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefpodoxime proxetil suspension compared with cefaclor suspension for treatment of acute otitis media in paediatric patients.
    MacLoughlin GJ; Barreto DG; de la Torre C; Pinetta EA; del Castillo F; Palma L
    J Antimicrob Chemother; 1996 Mar; 37(3):565-73. PubMed ID: 9182113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.